1727 related articles for article (PubMed ID: 21813061)
1. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
[TBL] [Abstract][Full Text] [Related]
2. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
Petrou S; Hockley C
Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
[TBL] [Abstract][Full Text] [Related]
3. Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients.
Zhao FL; Yue M; Yang H; Wang T; Wu JH; Li SC
Value Health; 2010 Aug; 13(5):649-56. PubMed ID: 20412540
[TBL] [Abstract][Full Text] [Related]
4. Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis.
Lillegraven S; Kristiansen IS; Kvien TK
Ann Rheum Dis; 2010 Oct; 69(10):1762-7. PubMed ID: 20448285
[TBL] [Abstract][Full Text] [Related]
5. A comparison between the EQ-5D and the SF-6D in patients with chronic obstructive pulmonary disease (COPD).
Chen J; Wong CK; McGhee SM; Pang PK; Yu WC
PLoS One; 2014; 9(11):e112389. PubMed ID: 25379673
[TBL] [Abstract][Full Text] [Related]
6. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH
Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort.
Gaujoux-Viala C; Rat AC; Guillemin F; Flipo RM; Fardellone P; Bourgeois P; Fautrel B
J Rheumatol; 2011 Aug; 38(8):1576-84. PubMed ID: 21532054
[TBL] [Abstract][Full Text] [Related]
8. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.
Li N; Boonen A; van den Bergh JP; van Kuijk SMJ; Wyers CE; van Oostwaard M; Vranken L; Bours SPG; Hiligsmann M
J Med Econ; 2022; 25(1):829-839. PubMed ID: 35674412
[TBL] [Abstract][Full Text] [Related]
9. An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand.
Dritsaki M; Petrou S; Williams M; Lamb SE
Health Qual Life Outcomes; 2017 Jan; 15(1):20. PubMed ID: 28118833
[TBL] [Abstract][Full Text] [Related]
10. Validation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients.
Wu J; Han Y; Zhao FL; Zhou J; Chen Z; Sun H
Health Qual Life Outcomes; 2014 Oct; 12():156. PubMed ID: 25343944
[TBL] [Abstract][Full Text] [Related]
11. Quality-adjusted life expectancies in patients with rheumatoid arthritis--comparison of index scores from EQ-5D, 15D, and SF-6D.
Sørensen J; Linde L; Ostergaard M; Hetland ML
Value Health; 2012; 15(2):334-9. PubMed ID: 22433765
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement.
Xie F; Li SC; Luo N; Lo NN; Yeo SJ; Yang KY; Fong KY; Thumboo J
Arthritis Rheum; 2007 Aug; 57(6):1043-9. PubMed ID: 17665466
[TBL] [Abstract][Full Text] [Related]
13. Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis.
Harrison MJ; Lunt M; Verstappen SM; Watson KD; Bansback NJ; Symmons DP
Health Qual Life Outcomes; 2010 Feb; 8():21. PubMed ID: 20149253
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the validity of two indirect utility instruments as measures of postoperative recovery.
Lee L; Mata J; Augustin BR; Carli F; Morin N; Latimer E; Feldman LS
J Surg Res; 2014 Jul; 190(1):79-86. PubMed ID: 24629417
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life and utility: comparison of ankylosing spondylitis, rheumatoid arthritis, and systemic lupus erythematosus patients in Taiwan.
Chen HH; Chen DY; Chen YM; Lai KL
Clin Rheumatol; 2017 Jan; 36(1):133-142. PubMed ID: 27837342
[TBL] [Abstract][Full Text] [Related]
16. Comparative responsiveness of the EuroQol-5D and Short Form 6D to improvement in patients with rheumatoid arthritis treated with tumor necrosis factor blockers: results of the Dutch Rheumatoid Arthritis Monitoring registry.
Buitinga L; Braakman-Jansen LM; Taal E; Kievit W; Visser H; van Riel PL; van de Laar MA
Arthritis Care Res (Hoboken); 2012 Jun; 64(6):826-32. PubMed ID: 22262513
[TBL] [Abstract][Full Text] [Related]
17. A head-to-head comparison of EQ-5D-5 L and SF-6D in Chinese patients with low back pain.
Ye Z; Sun L; Wang Q
Health Qual Life Outcomes; 2019 Apr; 17(1):57. PubMed ID: 30971265
[TBL] [Abstract][Full Text] [Related]
18. Comparison of EuroQol-5D and short form-6D utility scores in multiethnic Asian patients with psoriatic arthritis: a cross-sectional study.
Leung YY; Png ME; Wee HL; Thumboo J
J Rheumatol; 2013 Jun; 40(6):859-65. PubMed ID: 23504382
[TBL] [Abstract][Full Text] [Related]
19. Interchangeability of the EQ-5D and the SF-6D, and comparison of their psychometric properties in a spinal postoperative Spanish population.
Selva-Sevilla C; Ferrara P; Gerónimo-Pardo M
Eur J Health Econ; 2020 Jun; 21(4):649-662. PubMed ID: 32065301
[TBL] [Abstract][Full Text] [Related]
20. Understanding the relationship between the EQ-5D, SF-6D, HAQ and disease activity in inflammatory arthritis.
Adams R; Walsh C; Veale D; Bresnihan B; FitzGerald O; Barry M
Pharmacoeconomics; 2010; 28(6):477-87. PubMed ID: 20465316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]